REG - Judges ScientificPLC - Board Succession

Judges ScientificAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251126:nRSZ9847Ia&default-theme=true

RNS Number : 9847I  Judges Scientific PLC  26 November 2025

26 November 2025

Judges Scientific plc

 

("Judges Scientific", "Judges", "Group" or the "Company")

 

Board Succession

 

Judges Scientific, the group focused on acquiring and developing companies in
the scientific instrument sector, announces the following in relation to
Board succession.

 

Summary of changes with effect from 9(th) February 2026:

 ·         David Cicurel, CEO, steps up to Non-Executive Chair.
 ·         Promotion of Tim Prestidge, Group Business Development Director, to CEO.
 ·         Ralph Elman, Non-Executive Chair, becomes Non-Executive Deputy Chair.

 

David Cicurel, founder and Chief Executive Officer of Judges Scientific plc,
has advised the Board of his intention to step back from his role as Chief
Executive Officer on 9(th) February 2026. Since founding Judges more than 20
years ago, David has created and developed a decentralised group of
high-quality businesses focussed on generating increasing profits, high cash
conversion, and high returns on total invested capital. Over these two decades
the Group has delivered significant value for shareholders through earnings
per share growth and ever-increasing dividend returns. Importantly, the Group
retains an unparalleled reputation for its honest and ethical approach in all
business dealings, and as an excellent home and custodian for its growing
portfolio of niche scientific businesses.

 

The Board is delighted to announce that Dr Tim Prestidge, Group Business
Development Director, will succeed David as Chief Executive Officer. Tim
joined Judges in February 2023, having previously held senior leadership roles
at Halma plc, where he was Divisional CEO responsible for portfolios of
technology companies based in the UK, Europe, USA, and China, and Renishaw,
where he was Divisional CEO and an executive committee member. Since joining
Judges, Tim has held responsibility for various portfolios of the Group's
businesses, building on an outstanding reputation for encouraging ambition and
innovation and helping scientific businesses to achieve their potential. He
has also greatly contributed to the development and functioning of the Group
as a whole.

 

The Board's proposal for David to step up into the role of Non-Executive Chair
was confirmed following consultation with a number of the Group's largest
shareholders. Ralph Elman, the Group's current Non-Executive Chair, will
become Non-Executive Deputy Chair. David will also remain actively engaged in
the Group's acquisition processes, continuing to contribute his decades of
deal-making experience, and ensuring a seamless pursuit of Judges' long-term
business model and acquisition strategy. There are no changes to the
composition of any Board Committee at this point.

 

David Cicurel, Chief Executive Officer, commented: "The orchestration of
succession is not a short-term activity, and the time to implement a
transition is when one has the confidence that the new leadership generation
is in place, has the required competence to deliver growth in shareholder
value, and has internalised the Judges values which have made our Group
successful. Whilst choosing the perfect timing is never easy, particularly
given the present trading environment and the Company's recent results, we
have been preparing for this transition for several years, and I am delighted
that Tim will be taking over the reins. Tim is highly intelligent, focused,
hardworking, and has invaluable experience in our sector. I firmly believe
that he is the right person to lead Judges going forward.

With Tim, Brad Ormsby, Ian Wilcock, and the appointments of Rik Armitage, as
Group Acquisitions Executive, and John Dunne, who has recently joined from
Halma as a Portfolio Chief Executive, Judges is equipped with a top-quality
leadership team for the future. I have every confidence that the long-term
drivers of the Group's ability to deliver value for its shareholders are
intact and unaffected by recent turbulence, and I look forward to supporting
the Group's progress over the coming years."

 

Tim Prestidge, Chief Executive Officer designate, commented: "David has
founded and built an extraordinary Group, predicated on the basis that
long-term value creation and exceptional returns for shareholders can be
delivered within a framework of the utmost honesty and integrity in our
dealings with all stakeholders. It is a privilege to be given the opportunity
to lead and continue this legacy. With the strength of the leadership team
around me and throughout the Group's businesses, the resilience of our
long-term drivers, and our commitment to the fundamentals of Judges' strategy,
I have every confidence in the Group's continued success."

 

 

This announcement contains inside information for the purposes of Article 7 of
the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law
by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is
disclosed in accordance with the Company's obligations under Article 17 of
MAR.

 

 

For further information please contact:

 

 Judges Scientific plc                                        Shore Capital (Nominated Adviser & Joint Broker)

 David Cicurel, CEO                                           Stephane Auton

 Brad Ormsby, CFO                                             Harry Davies-Ball

 Tel: +44 (0) 20 3829 6970                                    Tel: +44 (0) 20 7408 4090

 Panmure Liberum (Joint Broker)                               Investec Bank plc (Joint Broker)

 Edward Mansfield                                             Virginia Bull

 William King                                                 Carlton Nelson

 Tel : +44 (0) 20 3100 2222                                   Tel: +44 (0) 20 7597 4000

 Alma (Financial Public Relations)

 Sam Modlin

 Rebecca Sanders-Hewett

 Joe Pederzolli

 Sarah Peters

 Tel: +44 (0) 20 3405 0205

 judges@almastrategic.com (mailto:judges@almastrategic.com)

 

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and
developing companies in the scientific instrument sector.  The Group consists
of 25 businesses acquired since 2005.

 

The acquired companies are primarily UK-based with products sold worldwide to
a diverse range of markets including higher education institutions, scientific
research facilities, manufacturers, and regulatory authorities.  The UK is
a recognised centre of excellence for scientific instruments.  The Group has
received five Queen's Awards for Innovation and Export.

 

The Group's companies predominantly operate in global niche markets, with long
term growth fundamentals and resilient margins.

 

Judges Scientific maintains a policy of selectively acquiring businesses that
generate sustainable profits and cash.  Shareholder returns are created
through the reduction of debt, organic growth, and dividends.

 

For further information, please visit www.judges.uk.com
(https://url.avanan.click/v2/r02/___http:/www.judges.uk.com/___.YXAxZTpzaG9yZWNhcDphOm86MTNmZDUyOGM3ZDBlODkzMGI2OThkM2QzYTM0ZDc1ZDI6Nzo5ZWMzOjJhZWRjNjE2OWQ5NmJmZjNiYjMzMTIyYTNmMDIxODEyZDNmZTgyMDUxMDc5OTEwYmZkZDBlMTRlZWZmNTAwOTg6cDpUOk4)

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAGZMZMRKGGKZM



            Copyright 2019 Regulatory News Service, all rights reserved